ArticleHuman vaccines & immunotherapeutics2025
Human papillomavirus vaccination among childhood cancer survivors: A scoping review.
Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Childhood cancer survivors are at increased risk for human papillomavirus (HPV) cancers yet are less likely to be vaccinated against HPV than the general population. This scoping review identified studies describing barriers, facilitators, and strategies to improve HPV vaccination in this vulnerable population. We searched PubMed, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Web of Science to identify full-length studies, published in English, from July 2006 to June 2024. We excluded survivorship studies unrelated to HPV vaccination and non-empirical studies (e.g. commentaries). Twenty studies were identified. Multi-level barriers reported occurred in patients- (e.g. vaccine safety-concerns), provider- (e.g. inconsistent guidelines), and system-levels (e.g. lack of vaccine availability). The primary facilitator was the health care provider's recommendation. Potential strategies for increased vaccination included clear recommendations and digital reminders. This review provides valuable insights for developing strategies to improve HPV vaccination coverage and reduce the risk of HPV-related cancers among childhood cancer survivors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.